AF
MRVI icon

Advisornet Financial’s Maravai LifeSciences MRVI Stock Holding History

Advisornet Financial’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6
Closed -$39 – 2344
2023
Q4 		$39 Buy
6
+5
+500% +$32 ﹤0.01% 2404
2023
Q3 		$10 Sell
1
-2
-67% -$22 ﹤0.01% 2276
2023
Q2 		$37 Hold
3
– – ﹤0.01% 2325
2023
Q1 		$42 Sell
3
-4
-57% -$57 ﹤0.01% 2364
2022
Q4 		$100 Buy
+7
New +$110 ﹤0.01% 2293
2022
Q3 		– Sell
-100
Closed -$3K – 1974
2022
Q2 		$3K Hold
100
– – ﹤0.01% 1627
2022
Q1 		$4K Sell
100
-5
-5% -$168 ﹤0.01% 1675
2021
Q4 		$4K Buy
105
+5
+5% +$203 ﹤0.01% 1706
2021
Q3 		$5K Buy
+100
New +$4.88K ﹤0.01% 1623

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Advisornet Financial's MRVI Position: Q1 2024 in Review

Advisornet Financial sold out of Maravai LifeSciences (MRVI) in Q1 2024, closing a stake of 6 shares — an estimated $39 sold.

Advisornet Financial first reported a position in MRVI in Q3 2021 and held it in 9 quarters. The position peaked at $5K in Q3 2021. 210 funds tracked by Wall St. Rank hold MRVI as of Q1 2024.

  • Advisornet Financial reported no remaining Maravai LifeSciences position as of Q1 2024 after selling out during the quarter.
  • Advisornet Financial sold 6 Maravai LifeSciences shares in Q1 2024, an estimated $39.
  • Advisornet Financial first reported a position in Maravai LifeSciences in Q3 2021 and held it in 9 quarters.
  • Advisornet Financial's Maravai LifeSciences position peaked at $5K in Q3 2021.
  • 210 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2024.

Based on Advisornet Financial's 13F filing for Q1 2024, filed 12 Apr 2024.